MDA5 signaling induces type 1 IFN- and IL-1-dependent lung vascular permeability which protects mice from

Michael J Davis1, Rachel E Martin1, Giovana M Pinheiro1

  • 1Molecular Microbiology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States.

Frontiers in Immunology
|August 15, 2022
PubMed

Insights

Poly(I:C) (pICLC) induces vascular permeability in the lungs, enhancing innate immunity against fungal infections like cryptococcosis by restricting iron availability.

Area of Science:

  • Immunology
  • Pulmonary Medicine
  • Infectious Diseases

Background:

  • The lungs face threats from viral infections, secondary infections, and inflammation.
  • Severe lung inflammation can lead to increased vascular permeability, edema, and organ dysfunction.
  • Previous studies showed poly(I:C) (pICLC) induced type 1 interferon (t1IFN) protected mice against *Cryptococcus gattii* (Cg) via iron restriction.

Purpose of the Study:

  • To investigate the mechanisms by which pICLC affects lung vascular permeability and its role in innate immunity.
  • To determine the signaling pathways involved in pICLC-induced vascular permeability and inflammation.
  • To explore the potential of induced vascular permeability as a host-directed therapeutic strategy against fungal infections.

Main Methods:

  • Mice were treated with pICLC to assess lung vascular permeability using serum protein and FITC-dextran leakage.
  • Gene expression analysis was performed to identify inflammatory signatures, focusing on IL-1, IL-6, and MDA5.
  • The roles of MDA5, t1IFN, IL-1, and IL-6 in vascular permeability were investigated.
  • The impact of pICLC-induced vascular permeability on Cg fungal burden was evaluated.

Main Results:

  • pICLC treatment increased lung vascular permeability, evidenced by elevated serum protein and FITC-dextran in the lung airspace.
  • pICLC induced a pro-inflammatory response characterized by increased IL-1 and IL-6 expression, dependent on MDA5 and t1IFN.
  • Vascular permeability was found to be dependent on MDA5, t1IFN, IL-1, and IL-6.
  • Positive feedback loops involving t1IFN and MDA5 signaling were suggested to enhance the pro-inflammatory response.
  • pICLC-induced vascular permeability inhibited Cg growth by limiting iron availability.

Conclusions:

  • pICLC induces t1IFN, which potentiates MDA5 signaling, leading to increased IL-1 and IL-6 production.
  • This results in enhanced vascular permeability and the leakage of antimicrobial factors into the lung airspace.
  • Induced vascular permeability may serve as an innate defense mechanism against opportunistic fungal infections like cryptococcosis.
  • This mechanism presents a potential host-directed therapeutic target for managing fungal infections.

Related Concept Videos